Next Article in Journal
Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Next Article in Special Issue
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
Previous Article in Journal
Chronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8+ T-Cell Dysfunction
Previous Article in Special Issue
Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessFeature PaperReview

Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics

1
School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK
2
Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds LS2 9JT, UK
3
Laboratorio de Transducción de señales y cáncer, Centro de Estudios Farmacológicos y Botánicos (CEFYBO-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina
*
Authors to whom correspondence should be addressed.
Cells 2019, 8(4), 375; https://doi.org/10.3390/cells8040375
Received: 2 April 2019 / Revised: 22 April 2019 / Accepted: 23 April 2019 / Published: 25 April 2019
(This article belongs to the Special Issue Targeting Hedgehog Signaling in Cancer)
  |  
PDF [672 KB, uploaded 25 April 2019]
  |  

Abstract

Breast cancer (BC) is the leading cause of cancer-related mortality in women, only followed by lung cancer. Given the importance of BC in public health, it is essential to identify biomarkers to predict prognosis, predetermine drug resistance and provide treatment guidelines that include personalized targeted therapies. The Hedgehog (Hh) signaling pathway plays an essential role in embryonic development, tissue regeneration, and stem cell renewal. Several lines of evidence endorse the important role of canonical and non-canonical Hh signaling in BC. In this comprehensive review we discuss the role of Hh signaling in breast development and homeostasis and its contribution to tumorigenesis and progression of different subtypes of BC. We also examine the efficacy of agents targeting different components of the Hh pathway both in preclinical models and in clinical trials. The contribution of the Hh pathway in BC tumorigenesis and progression, its prognostic role, and its value as a therapeutic target vary according to the molecular, clinical, and histopathological characteristics of the BC patients. The evidence presented here highlights the relevance of the Hh signaling in BC, and suggest that this pathway is key for BC progression and metastasis. View Full-Text
Keywords: hedgehog; breast cancer; clinical trial; sonic; Patched-1; Smoothened; glioma-associated oncogene; TNBC; therapeutics hedgehog; breast cancer; clinical trial; sonic; Patched-1; Smoothened; glioma-associated oncogene; TNBC; therapeutics
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Riobo-Del Galdo, N.A.; Lara Montero, Á.; Wertheimer, E.V. Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. Cells 2019, 8, 375.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top